BIRC5 and type 2 diabetes mellitus: Previous studies have demonstrated that 4-MU can ameliorate Type 2 diabetes, suggesting that its use as a hyaluronic acid inhibitor not only alleviates HA deposition in t2d islets, but may also protect β cells from injury by increasing the expression of survivin, an inhibitor of apoptosis.